31. P613 Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors. (21st January 2022) Authors: Onali, S; Pugliese, D; Caprioli, F A; Orlando, A; Biancone, L; Nardone, O M; Imperatore, N; Fiorino, G; Cappello, M; Viola, A; Principi, M B; Bezzio, C; Aratari, A; Carparelli, S; Mazzuoli, S; Manguso, F; Grossi, L; Bodini, G; Ribaldone, D; Mocci, G Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i542 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
32. P644 Effectiveness of vedolizumab on intestinal outcomes and articular manifestations: Real-world data from the Sicilian Network for inflammatory bowel disease (SN-IBD). (16th January 2018) Authors: Macaluso, F S; Orlando, R; Fries, W; Scolaro, M; Magnano, A; Pluchino, D; Cappello, M; Morreale, G C; Siringo, S; Privitera, A C; Ferracane, C; Belluardo, N; Alberghina, N; Ventimiglia, M; Rizzuto, G; Renna, S; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
33. P690 Comparative efficacy of vedolizumab and adalimumab as second-line therapy in ulcerative colitis patients previously treated with infliximab. (25th January 2019) Authors: Favale, A; Onali, S; Caprioli, F; Pugliese, D; Armuzzi, A; Macaluso, F S; Orlando, A; Viola, A; Fries, W; Mocci, G; Chicco, F; Usai, P; Rispo, A; Castiglione, F; Calabrese, E; Biancone, L; Monteleone, G; Fantini, M C Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
34. P703 The real-world long-term effectiveness of vedolizumab in inflammatory bowel diseases: a single-centre observational study. (25th January 2019) Authors: Macaluso, F S; Croce, A; Orlando, R; Ventimiglia, M; Sapienza, C; Gambino, F; Orlando, E; Grova, M; Rizzuto, G; Renna, S; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S472 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
35. P727 Effectiveness and Safety of Vedolizumab in Inflammatory Bowel Disease: A Comprehensive Meta-analysis of Observational Studies. (30th January 2023) Authors: Macaluso, F S; Ventimiglia, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
36. P732 Endoscopic Balloon Dilation Of Symptomatic Intestinal Crohn's disease Strictures: Long-Term Data On Efficacy And Safety In A Cohort Of Patients Followed-up For 10 Years. (25th January 2019) Authors: Scimeca, D; Mocciaro, F; Di Mitri, R; Giunta, M; Renna, S; Teresi, G; Conte, E; Bonaccorso, A; Casà, A; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
37. P737 SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis. (25th January 2019) Authors: Macaluso, F S; Cappello, M; Giuffrida, E; Fries, W; Centritto, A; Privitera, A C; Inserra, G; Vassallo, R; Magnano, A; Vinci, E; Garufi, S; Ventimiglia, M; Renna, S; Orlando, R; Rizzuto, G; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
38. P801 Physicians' knowledge and application of immunisation strategies in patients with inflammatory bowel disease: a survey by the Italian Group for the study of inflammatory bowel disease (IG-IBD). (25th January 2019) Authors: Macaluso, F S; Mazzola, G; Ventimiglia, M; Alvisi, P; Renna, S; Adamoli, L; Galli, M; Armuzzi, A; Ardizzone, S; Cascio, A; Cottone, M; Orlando, A Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
39. P802 Perforating Crohn's Disease and pancolitis as risk factors for incident cancer: a prospective multi-centre nested case–control IG-IBD study at 6 years. (25th January 2019) Authors: Petruzziello, C; Armuzzi, A; Scribano, M L; Castiglione, F; D'incà, R; Daperno, M; Papi, C; Vecchi, M; Fries, W; Riegler, G; Alvisi, P; Mocciaro, F; Neri, B; Festa, S; Testa, A; Calabrese, E; Di Mitri, R; De Crstofaro, E; Gesuale, C; Spina, L Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
40. Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis. (9th January 2019) Authors: Felice, C; Leccese, P; Scudeller, L; Lubrano, E; Cantini, F; Castiglione, F; Gionchetti, P; Orlando, A; Salvarani, C; Scarpa, R; Vecchi, M; Olivieri, I; Armuzzi, A Journal: Clinical and experimental immunology Issue: Volume 196:Number 1(2019) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗